e-learning
resources
Milan 2017
Monday, 11.09.2017
Obstructive and central sleep apnoea: consequences and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis
M. Arzt (Regensburg, Germany)
Source:
International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Session:
Obstructive and central sleep apnoea: consequences and comorbidities
Session type:
Thematic Poster
Number:
2329
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arzt (Regensburg, Germany). Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis. 2329
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Application of machine learning algorithms to predict loss of asthma control: A post-hoc analysis of INCONTRO study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure:
post hoc
analysis of a randomised clinical trial
Source: ERJ Open Res, 7 (4) 00418-2021; 10.1183/23120541.00418-2021
Year: 2021
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Are carbapenems a better antibiotic than others for treat ICU-AP? A post-hoc analysis of a prospective cohort.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Treatment response in COPD: does FEV
1
say it all? A
post hoc
analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019
Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a
post hoc
analysis from a randomised controlled trial
Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Year: 2018
Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
Validation of the codex index in patients with COPD enrolled in randomized clinical trials: A post-hoc analysis of the trilogy, trinity and tribute studies.
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
Symptom improvement over time with umeclidinium/vilanterol versus monotherapy: a post-hoc analysis of the EMAX trial
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
2-way remote monitoring in adaptive mode allows effective and realistic provision of home Non-Invasive Ventilation(NIV) to patients with severe COPD
Source: International Congress 2018 – New insights in the management of chronic respiratory failure
Year: 2018
Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Circulating desmosine as a biomarker of azithromycin treatment response: a
post hoc
analysis of the COLUMBUS randomised controlled trial
Source: ERJ Open Res, 4 (4) 00136-2018; 10.1183/23120541.00136-2018
Year: 2018
Accuracy of objective tests for diagnosing adult asthma in symptomatic patients: A systematic literature review and hierarchical Bayesian latent-class meta-analysis.
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Comparative assessment of several automatic CPAP devices' responses: a bench test study
Source: ERJ Open Res 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept